Fundraising FoxTorrey Pines Investment
Venture capitalSan Diego · Seed–Series A · 7 people tracked
Find your way into Torrey Pines Investment
Sign up to see every warm intro you have to Torrey Pines Investment
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Torrey Pines Investment team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Torrey Pines Investment focuses on the life-sciences sector, backing biopharma and diagnostics accelerators and investing in early development-stage assets from pharma and biotech partners across CNS, oncology, and virology areas. The firm aims to advance these assets toward success through pharma partnering and M&A. It supports portfolio companies with both product and corporate development, drawing on expertise in drug discovery — including non-clinical and clinical studies, manufacturing and quality, and regulatory affairs — to help them achieve growth, build value, and realize wealth.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 10 of 13 portfolio companiesBiotech ×8Healthtech ×7Medical Devices ×3AI & Machine Learning ×2Deep Tech ×2Digital Health ×2Marketing Tech ×1SaaS ×1
HQs:United States×5Finland×1
Investments · 13 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12018 · 12016 · 12014 · 15 dated
Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.
BiotechHealthtechPhiladelphia, US
Martin Lehr(Founder)inJennifer Minai-Azary(Executive Officer)inAlex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)Philip Kantoff(Director)in
Co-investorsNextech InvestOUP (Osage University Partners)
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.
AI & Machine LearningBiotechHealthtechDover, US
Megan McGill(Chief Executive Officer)inIain Dukes(Chief Business Officer / Chairman of the Board)inNikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in
Co-investorsNew Enterprise Associates (NEA)OrbiMedBGV
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtechSan Diego, US
Co-investorsBioGeneration VenturesOrbiMedBGV
19Labs builds GALE, a smart point-of-care platform that brings a full clinic experience to schools, rural communities, and pharmacies.
Digital HealthHealthtechMedical Devices
Ram Fish(Founder & CEO)inGerald Horel(Founder)in
Co-investorsTransPacific Venture Partners
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Co-investorsAlexandria
Chromis Therapeutics is a biotech company with board members experienced in pharmaceutical development, corporate development, and healthcare investments.
BiotechHealthtechMedical DevicesSan Diego, US
BoardNikolay Savchuk(Chairman of the Board)Ronald Demuth(Director of the Board)Jennifer Giottonini Cayer(Director of the Board)
Elpida provides automated regulatory compliance monitoring for healthcare brands' digital communications.
AI & Machine LearningHealthtechMarketing TechSaaS
Co-investorsfresh.fundSkolkovo Foundation
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases.
BiotechDeep Tech
Timo(Scientific Co-founder)inErik(Scientific Co-founder)inSimon(Chief Executive Officer)inSebastian(Chief Operating Officer)in
Co-investorsInnovestor
Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
Co-investorsOneVenturesR&D Tax Incentive
Viriom Inc. develops a pipeline of treatments for infectious diseases (blood-borne and respiratory viral diseases) and malignant diseases (solid tumors) through a global drug development platform built with partner networks.
Biotech
Co-investorsSkolkovo Foundation
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Exits · 1
1 IPOsContext TherapeuticsNASDAQ: CNTX
Frequently asked questions
- How many investments has Torrey Pines Investment made?
- Torrey Pines Investment has 13 tracked investments, 1 of which have exited.
- What stage does Torrey Pines Investment invest at?
- Torrey Pines Investment invests at the Seed, Series A stages.
- What sectors does Torrey Pines Investment focus on?
- Torrey Pines Investment focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Torrey Pines Investment located?
- Torrey Pines Investment is headquartered in San Diego, US.
- Does Torrey Pines Investment lead rounds?
- Yes, Torrey Pines Investment leads investment rounds.
- Who does Torrey Pines Investment co-invest with?
- Torrey Pines Investment most often shares deals with Nextech Invest, OneVentures, OUP (Osage University Partners), among 4 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.